Vitamin D Doesn't Improve Glucose Measures

However, significant improvement in LDL cholesterol seen in those with diabetes risk
diabetes testing
diabetes testing

WEDNESDAY, Oct. 5, 2016 (HealthDay News) -- Weekly doses of vitamin D do not improve oral glucose tolerance or markers of glycemic status among those at risk for diabetes, according to a study published online Sept. 26 in Diabetes, Obesity and Metabolism.

Tracy S. Moreira-Lucas, Ph.D., from the University of Toronto, and colleagues conducted a 24-week randomized, placebo-controlled trial to study the effect of 28,000 IU of vitamin D3 once weekly on plasma glucose after a two-hour, 75-g oral glucose tolerance test (2hrPC glucose); insulin sensitivity; and beta-cell function. Of 71 participants with serum 5-hydroxyvitamin-D (25[OH]D) ≤65 nmol/L, impaired fasting glucose, and elevated glycated hemoglobin, 35 subjects received vitamin D and 36 received placebo.

The researchers found that serum 25(OH)D significantly increased in the vitamin D group. However, no significant differences in fasting or 2hPC glucose or other indices of glucose metabolism, including beta-cell function and insulin sensitivity, were seen. The results were similar in a subgroup analysis of individuals with 25(OH)D <50nmol/L and prediabetes. The vitamin D group did show a significant reduction in low-density lipoprotein cholesterol.

"Weekly doses of vitamin D3 in individuals with sub-optimal vitamin D and at risk for type 2 diabetes did not improve oral glucose tolerance or markers of glycemic status," the authors write.

Abstract
Full Text (subscription or payment may be required)

Related Stories

No stories found.
logo
www.healthday.com